TotalMarketCap

Eton Pharmaceuticals

ETONNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.347 B

$47.12 -7.10%

Close of 6 Nov 2026

As of 6 Nov 2026, Eton Pharmaceuticals (ETON) has a market capitalization of $1.35B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$80.0M

#2564 by revenue

Earnings

-$4.60M

Loss-making

Shares outstanding

28,842,215

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #127Mineralys TherapeuticsMLYS$1.35B
  2. #128AnaptysbioANAB$1.35B
  3. #129Eton PharmaceuticalsETON$1.35B
  4. #130KardiganKARD$1.30B
  5. #131Opko HealthOPK$1.30B

What if Eton Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$987,885.82

Per share 20,965× higher

Bitcoin $1.53T

$53,452.78

Per share 1,134× higher

Apple $5.02T

$175,480.49

Per share 3,724× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for Eton Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.